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Mousehin the pharyngeal apparatus from endodermally-derived cells. The many
derivatives of the pharyngeal apparatus develop at similar times and sometimes from common cell types,
explaining why many syndromic disorders express multiple birth defects affecting different structures that
share a common pharyngeal origin. Thus, different derivatives may share common genetic networks during
their development. Tbx1, the major gene associated with DiGeorge syndrome, is a key player in the global
development of the pharyngeal apparatus, being required for virtually all its derivatives, including the
thyroid. Here we show that Tbx1 regulates the size of the early thyroid primordium through its expression in
the adjacent mesoderm. Because Tbx1 regulates the expression of Fgf8 in the mesoderm, we postulated that
Fgf8 mediates critical Tbx1-dependent interactions between mesodermal cells and endodermal thyrocyte
progenitors. Indeed, conditional ablation of Fgf8 in Tbx1-expressing cells caused an early thyroid phenotype
similar to that of Tbx1 mutant mice. In addition, expression of an Fgf8 cDNA in the Tbx1 domain rescued the
early size defect of the thyroid primordium in Tbx1 mutants. Thus, we have established that a Tbx1-NFgf8
pathway in the pharyngeal mesoderm is a key size regulator of mammalian thyroid.
© 2009 Elsevier Inc. All rights reserved.Introduction
The thyroid is an endocrine gland that secretes two types of
hormones, thyroxin and calcitonin, which are produced by two
distinct cell types, the thyroid follicular cells (TFC) and the para-
follicular or C-cells, respectively. These two cell types derive from
distinct regions of the pharyngeal endoderm, speciﬁcally the ventral
the pharyngeal endoderm provides the TFC progenitors, while the
endoderm of the 4th pharyngeal pouches provides the C-cell
progenitors. The TFC progenitor population constitutes the early
primordium at approximately embryonic day (E) 8.5, when it appears
as thickened epithelium on the ventral-medial wall of the pharynx,
just caudal to the 1st pharyngeal arch. The early primordium then
grows without further cell proliferation (Fagman et al., 2006)
presumably by recruiting cells from the adjacent endoderm, and
forms a pit by invaginating into the pharyngeal mesenchyme.
Between E11.5 and E13.5, the primordium grows deeper into the
mesenchyme, detaches from the pharyngeal endoderm, and begins to
expand laterally. Later, the thyroid primordium reaches the tracheaBiophysics, CNR, Via Pietro
l rights reserved.where it fuses with the 4th pouch-derived ultimobranchial bodies,
which provide the C-cells of themature organ. At around E15–E16, the
thyroid gland acquires its ﬁnal shape, i.e. two lobes connected by a
narrow isthmus. From this stage, the organ grows and begins to
express functional markers such as thyroglobulin (tg), thyroperox-
idase (TPO) and Tshr (De Felice, 2004).
The signals that induce the initial events of speciﬁcation and
migration of thyroid precursor cells are still unknown. It has been
postulated that the invagination process involves epithelial–mesench-
yme transition. However, recently it has been demonstrated that the
epithelial phenotype is maintained by thyroid progenitor cells
throughout organogenesis (Fagman et al., 2003). Indeed, thyroid
precursors express high levels of E-cadherin, which is epithelial cell-
speciﬁc, throughout development (Fagman et al., 2003), suggesting
that the invagination is not associated with transition and active
migration, but rather it might be due to passive movement of the
primordium along with remodeling of the surrounding mesenchyme.
In addition, it has been shown a cell autonomous role of Foxe2 in the
migration process (De Felice et al., 1998). The disruption of thyroid
morphogenesis associated with mutations of genes expressed in
tissues surrounding the primordium, e.g. Shh and Hoxa5, demon-
strates the importance of tissue interactions during thyroid develop-
ment (Fagman et al., 2004; Meunier et al., 2003).
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defects of the derivatives of the pharyngeal apparatus that result in
many birth defects, including cardiovascular, craniofacial and ear
defects (Scambler, 1993; Shprintzen et al., 2005). DGS patients also
show developmental abnormalities of pharyngeal-derived glands
such as the thymus, parathyroids and, in some cases, thyroid (Bassett
and Thakker, 1995; Scuccimarri and Rodd, 1998). Consistent with this,
mice mutated for Tbx1, a key gene in the pathogenesis of DGS,
recapitulate most, if not all, the above mentioned abnormalities
(Baldini, 2005), including thyroid abnormalities (Fagman et al., 2007;
Liao et al., 2004).
Tbx1 encodes a T-box transcription factor that is expressed
regionally and dynamically in the ectoderm, endoderm and meso-
derm of the developing pharyngeal apparatus. The endodermal
expression domain encompasses the dorsal and lateral aspects of
the pharynx but does not include the thyroid domain, while the
mesodermal expression domain is adjacent to and partially surrounds
the thyroid domain.
The thyroid primordium and the ultimobranchial bodies, which
derive from the 4th pharyngeal pouches, fuse at E13 and contribute to
the mature gland. Tbx1-null mutants do not have 4th pharyngeal
pouches, thus thyroid hypoplasia in these mutants could be explained
in part by the absence of the ultimobranchial bodies-derived
component of the mature organ (Liao et al., 2004). However, loss of
Tbx1 already affects thyroid development at E11.5 (Fagman et al.,
2007), indicating that loss of the 4th pharyngeal pouch is insufﬁcient
to explain the phenotype.
In this study, we show that Tbx1-dependent signals from the
mesoderm are required to ensure that the proper number of
endodermally-derived thyroid precursors populate the primordium.
We provide genetic evidence that Fgf8 is a critical intermediary of
this function because 1) Tbx1 positively regulates Fgf8 expression in
the mesoderm, 2) removal of Fgf8 from Tbx1-expressing cells causes
thyroid hypoplasia, 3) forced expression of Fgf8 from the endogenous
Tbx1 locus partially rescues the thyroid phenotype in Tbx1 mutants.
It has been shown that Fgf10 (also expressed in mesoderm) and its
receptor Fgfr2 are required for thyroid development (Celli et al., 1998;
De Felice, 2004; Ohuchi et al., 2000). However, Fgf8 has not been
implicated in mammalian thyroid morphogenesis until now. Our data
support a Tbx1-dependent role for Fgf8 in thyroid development, and
they are consistent with a recent report showing a critical role of this
gene in zebraﬁsh thyroid development (Wendl et al., 2007). In
addition, our data show that pharyngeal mesoderm (including the
cardiogenic mesoderm of the secondary heart ﬁeld) supports thyroid
development, thus providing a possible explanation for the frequent
association between congenital heart disease and thyroid dysmor-
phogenesis (Olivieri et al., 2002).
Materials and methods
Mouse lines
The followingmouse lines have been described: Tbx1+/− (Lindsay et
al., 2001), Tbx1Cre/+ (Huynh et al., 2007), Tbx1ﬂox/ﬂox (Xu et al., 2004),
Tbx1ΔE5/+ (a null allele, (Xu et al., 2004)), Tbx1Fgf8/+ (Vitelli et al., 2006),
Mesp1Cre/+ (Saga et al., 1999), Fgf8ﬂox/ﬂox (Meyers et al., 1998), Tie2Cre
(Kisanuki et al., 2001), Foxa2mcm/+ (Park et al., 2008), Fgfr1ﬂox/ﬂox (Xu et
al., 2002), Fgfr2ﬂox/ﬂox (Yu et al., 2003), and R26R (Soriano, 1999). All
lines were backcrossed into the C57Bl/6 genetic background for at
least two generations. PCR strategies for mouse genotyping have been
described in the original reports. For ablation of FgfR1 and FgfR2 in the
pharyngeal endoderm by E8.0, pregnant females were orally gavaged
with 0.05 mg/g body weight tamoxifen at E6.75 as described in (Park
et al., 2008).
We have examined at least 3–5 embryos per experimental point
and developmental stage.Immunohistochemistry and in situ hybridization
Mouse embryos or dissected thyroids were collected in phosphate
buffered saline (PBS), and ﬁxed in 4% paraformaldehyde overnight.
Following ﬁxation, embryos were dehydrated through graded etha-
nols, embedded in parafﬁn wax and sectioned (7 μm). Sections were
dewaxed by standard techniques, and heat-treated for the antigen
retrieval. To quench endogenous peroxidases, sections were treated
with hydrogen peroxide in methanol at room temperature. Sections
were incubated for 1 h at room temperature with blocking solution
(3% BSA, 5% goat serum, 20 mM MgCl2, 0.3% Tween 20 in PBS) and
then with primary antibodies overnight at 4 °C. Staining procedures
and chromogenic reactions were carried out according to the
protocols of the Vectastain ABC kit protocol (Vector Laboratories).
The primary antibodies used were: anti Titf1/Nkx2.1 (kindly provided
by Dr R. Di Lauro), anti-human Thyroglobulin (Tg, Dako), anti
phosphorylated histone H3 (Upstate), anti-Fgf8 (MAB323, R&D
Systems), and anti-Fgfr4 (H-121, Santa Cruz). For morphological
analyses, thyroid sections were dewaxed and stained with Hematox-
ylin and Eosin. Digital images from serial histological sections were
used for 3-dimensional reconstructions using the software WinSURF
(provided by SurfDriver, http://www.surfdriver.com/).
Cell counts of thyroid primordia (E9.0–E11.0) were carried out
using high magniﬁcation microscopy on consecutive tissue sections
and counting all the cells of the primordia.
Non radioactive in situ hybridization experiments were carried out
using standard methods and probes for Tbx1, Fgf8, Fgfr1, Fgfr2, Fgfr3
and Fgfr4.
Beta-galactosidase detection
Mouse embryos were ﬁxed in 4% paraformaldehyde and processed
for X-gal staining according to standard procedure. Embryos were
embedded in parafﬁn wax and sectioned (10 μm). Sections were
counterstained with nuclear fast red.
Results
Tbx1 is required in early thyroid development
The thyroid of E17.5 Tbx1−/− embryos is hypoplastic (Fagman et al.,
2007; Liao et al., 2004). However, the primary developmental defects
of thyroidogenesis caused by Tbx1 loss of function are unknown. To
deﬁne the mutant phenotype during development, we carried out a
morphological analysis of the thyroid and thyroid primordium at
different embryonic stages. Consistent with previously reported data
(Fagman et al., 2007), we found that at E18.5, Tbx1−/− embryos had
hypoplastic thyroid that was sometimes correctly located close to the
cricoid cartilage, and was formed by very small left and right lobes
(Fig. 1a') or, in most cases, by a single lobe (Fig. 5b'). In addition, we
observed that the lumen of thyroid follicles of mutant embryos
appeared slightly enlarged (Figs. 1a', b'). Immunohistochemistry
revealed that Nkx2-1 is normally expressed and that thyroglobulin is
normally produced by mutant follicles (Fig. 1c').
The thyroid primordiumwas clearly identiﬁable from E9.0, when it
appeared as a well-organized bi-layer of cells in the ventral endoderm
of the primitive pharynx, that stained with anti Nkx2-1 immunohis-
tochemistry (Fig. 2a). In Tbx1−/− embryos, we observed that Nkx2-1+
cells are not organized in a cell bi-layer, but appeared clustered (Fig.
2a'). At E9.5, thyroid precursor cells of wild type embryos invaded the
surrounding mesenchyme to form the thyroid primordium. In Tbx1−/−
embryos, the thyroid primordium was ﬂatter than in controls (Fig.
2b'). At E10, the migration of the thyroid primordium toward the
aortic sac was delayed in mutants (Fig. 2c'), and we observed
persistence of the thyroglossal duct, which constitutes a continuity
between the primordium and the pharyngeal endoderm (arrowhead
Fig.1.Hypoplasia and dysmorphogenesis of the thyroid in Tbx1−/− embryos at E18.5. Hematoxylin and eosin staining of histological sections fromwild type andmutant thyroids (a, a').
Immunohistochemistry with anti-Nkx2-1(b, b') and anti-Tg (c, c') antibodies demonstrates the presence of differentiated and functional thyroid follicular cells. Cc cricoid cartilage,
Th thyroid, Tr trachea. The scale bar is 50 μm.
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observed, we quantiﬁed its size by counting the number of Nkx2-1+
cells at E9.0–E10.5 (14–40 somites). Results showed a signiﬁcant
reduction of Nkx2-1+ cells at all stages tested (Table 1).
These data show that the mutant thyroid primordium is abnormal
from the earliest stages of its development (14 somites), in terms of
morphology and cell number, but known differentiation markers of
the primordium, such as Tg, Nkx2-1, Foxe1, Pax8, and Hhex1 were
expressed normally (Fig. 2 and supplementary Fig. 1). In some
experiments (for example see supplementary Fig. 1), Foxe1 immu-
nostaining appeared slightly increased in the Tbx1−/− samples.
However, repeated experiments could not conﬁrm this difference.
Mesodermal expression of Tbx1 regulates the size of the
thyroid primordium
Tbx1 is not expressed in the thyroid primordium (Fig. 3a) but it is
strongly expressed in the surrounding mesoderm and in thepharyngeal endoderm lateral to the primordium. In order to test
whether Tbx1 is expressed in endodermal precursors of the thyroid
primordium, we used a Tbx1Cre knock-in line (Huynh et al., 2007) in
combination with the R26R reporter (Soriano, 1999), to label the
progeny of Tbx1-expressing cells. We examined E9.5 Tbx1Cre/+;R26R
embryos and found very few (1–3) β-gal+ cells in the thyroid
primordium (Fig. 3a'), indicating that Tbx1-expressing cells do not
represent an important source of thyroid cells. Thus, the role of Tbx1 in
the thyroid primordium must be cell non-autonomous. Because Tbx1
is expressed in neighboring mesodermal cells ((Fagman et al., 2007)
and Fig. 3a), we hypothesized that there may be a Tbx1-dependent
signal in this tissue. To address this hypothesis, we eliminated Tbx1 in
mesodermal cells using the Mesp1Cre driver (Saga et al., 1999). The
ability of Mesp1Cre to delete Tbx1 exclusively in the mesoderm has
been demonstrated previously (Zhang et al., 2006). We examined the
thyroid size in Mesp1Cre/+;Tbx1ΔE5/ﬂ embryos (M-ko mutants) at two
embryonic stage, E9.5–10 and E18.5, using Nkx2-1 as amarker. At both
stages, we found a strong reduction of organ size, similar to Tbx1−/−
Fig. 2. Early abnormalities of the thyroid primordium in Tbx1 mutants. (a–c') Nkx2-1immunohistochemistry on sagittal sections of wild type (a–c) and Tbx1-null (a'–c') embryos at
E9, E9.5 and E10.5. The mutant thyroid primordium (14 somites) has lost the characteristic bi-layer cell morphology (compare insets in a' and a). At E9.5, the mutant thyroid
primordium is ﬂatter than inwild type (b, b'), while at E10.5 it is clearly smaller thanwild type and shows a persistent thyroglossal duct (white arrow). Ao aortic arch. The scale bar is
100 μm.
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thyroid development. We postulated that Tbx1 may have a positive,
cell non-autonomous effect on endodermal cell proliferation, thus
indirectly controlling the number of endodermal cells destined to
become thyroid cells. To test this, we evaluated cell proliferation in the
ventral endoderm of M-ko mutants at E8.5. Results showed a
signiﬁcant reduction of cell proliferation in M-ko embryos (Table 2,
an example of data is shown on supplementary Fig. 2) suggesting that
the reduced size of the primordium may be due to a reduced number
of thyroid precursors or to their reduced proliferation at early stages of
development.Table 1
Cell count (n cells) of thyroid primordia in embryoswith the genotype and developmental
stages indicated
Age Tbx1+/+ Tbx1−/− Tbx1Cre/+;Fgf8ﬂ/−
Som. n cells Som. n cells Som. n cells
E9 16 s 369 14 s 152
14 s 360 14 s 144
P=0.001
E9.5 24 s 438 25 s 127 24–26 s 271
22 s 515 21 s 306 250
22 s 615 22 s 392 170
P=0.008 P=0.03
E10.5–11 40 s 540 40 s 479
39 s 600 39 s 390
39 s 635 39 s 320
38 s 696 38 s 190
P=0.03
Som: somite stage. P values are referred to comparisons with wild type counts.Thyroid morphogenesis requires expression of Fgf8 in
Tbx1-expressing cells
Tbx1 regulates Fgf8 expression in the secondary heart ﬁeld (Hu et
al., 2004; Zhang et al., 2006), a mesodermal population located lateral
and ventral to the pharyngeal endoderm. This expression domain is
located just caudal to the thyroid primordium at E9.0 (Figs. 4a, a') and
is abolished inM-ko embryos (Figs. 4b, b'). At later stages we could not
identify any mesenchymal expression domain near the thyroid
primordium (stages tested: E10.5, E11.5, and E14.5, data not shown).
It has been shown that mesodermal Fgf8 is important for endodermal
cell proliferation (Park et al., 2006). Therefore, we tested whether Fgf8
may function as the Tbx1-dependent extra cellular signal critical for
thyroid growth. To establish whether Fgf8 expression in Tbx1-
expressing cells is important for thyroid development, we condition-
ally deleted the gene using a Tbx1Cre driver with a conditional (ﬂoxed)
allele of Fgf8 indicated as Fgf8ﬂ (Meyers et al., 1998). We observed that
the thyroid of Tbx1Cre/+;Fgf8ﬂ/− embryos at E9.5 (Figs. 4c, c') and E18.5
(Figs. 4d, d') is smaller than in controls. Complete cell counts of thyroid
primordia conﬁrmed the signiﬁcant reduction of primordium size at
E9.5 (Table 1). Three dimensional reconstruction of histological
sections from E18.5 organs illustrates these differences (compare
Figs. 5a', b' and c').
Thus, Tbx1-expressing cells represent a source of Fgf8 important
for thyroid morphogenesis.
Fgf8 expression in the Tbx1 domain partially rescues the Tbx1−/−
thyroid phenotype
If loss of Fgf8 expression in the Tbx1 domain is part of the
pathogenetic mechanism leading to thyroid hypoplasia in Tbx1−/−
Fig. 3. Thyroid development requires Tbx1 expression in the mesoderm. (a) Transverse section of an X-gal stained, Tbx1lacZ/+ E8.5 embryo showing Tbx1 expression in the
mesenchyme adjacent to the thyroid primordium (arrows) but not in the primordium itself (arrowhead). (a') cell fate analysis in Tbx1Cre/+; R26R mice. A group of β-gal+ cells
surrounds the thyroid primordium (black arrow) but no labeling is visible within the primordium. (b–c) The thyroid phenotype in Mesp1Cre/+;Tbx1flox/− embryos at E9.5 and E18.5.
Nkx2-1immunohistochemistry on sagittal sections of mutant embryos at E9.5 (b') reveals a differentiated thyroid primordium that is smaller and ﬂatter than in controls (b). (c, c') Tg
immunohistochemistry of Mesp1Cre/+;Tbx1flox/− mutant embryos at E18.5. Ao aortic arch, Tr trachea. The scale bar is 100 μm.
Table 2
Mitotic index (number of PH3+cells over the total) in the ventral region of the pharyngeal
endoderm of E8.5 embryos (3 controls and 3 M-ko, somite-matched)
Mesp1cre/+;Tbx1ΔE5/+ Mesp1cre/+;Tbx1ΔE5/ﬂox
Total cell number Mitotic index Total cell number Mitotic index
828 0.11 644 0.08
542 0.09 680 0.03
839 0.11 737 0.07
Pb0.05
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ameliorate the Tbx1−/− thyroid phenotype. To test this idea, we used
the Tbx1Fgf8 allele in which an Fgf8 cDNA has been knocked into the
Tbx1 locus (Vitelli et al., 2006). In these animals, the Fgf8 cDNA is
expressed in the Tbx1 domain and the Tbx1 gene in which the cDNA
has been inserted is not functional. Thus, Tbx1Fgf8/− embryos are null
for Tbx1, but express Fgf8. We harvested Tbx1Fgf8/− and Tbx1Fgf8/Fgf8
embryos at E10.5 and carried out cell counts of thyroid primordia.
Results showed that the cell number of knock-in embryos was not
Fig. 4. Ablation of Fgf8 in Tbx1-expressing cells causes thyroid hypoplasia. Transverse sections of E9.0 embryos show Fgf8 expression in themesoderm (black arrow in a') caudal to the
thyroid primordium, indicated as Th in the more cranial sections, a and b, in control and Mko embryos (a, a', and b, b', respectively). Note the down regulation of the mesodermal
domain in the M-ko embryo. Nkx2.1 immunohistochemistry in control (c) and Tbx1Cre/+;Fgf8ﬂox/− E9.5 embryos (c') reveals a differentiated but smaller thyroid in embryos with
conditional ablation of Fgf8. Similarly, at E18.5, Tg immunohistochemistry reveals a small thyroid in a Tbx1Cre/+;Fgf8ﬂox/− embryo (d') compared to wild type (d). The scale bar is 50 μm.
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also carried out histological analyses of Tbx1Fgf8/− E18.5 embryos.
Results indicated that Tbx1Fgf8/− thyroids are substantially larger than
in Tbx1−/− embryos (compare Figs. 5b, b' and d, d'), although they have
abnormal morphology, mostly limited to a large lobe (compare with
control, Fig. 5a'). These data demonstrate a partial rescue of the Tbx1−/−
thyroid size phenotype and support a pathogenetic role of Fgf8 dosage
reduction in the thyroid phenotype of Tbx1−/− embryos.
Next, we addressed the question as to which FGF receptor may
mediate the response of the pharyngeal endoderm/thyroid primor-
dium to Fgf8. Because it has been shown that Fgfr1 and Fgfr2 are
expressed in this tissue, and because conditional alleles are availablefor these genes, we have deleted both these genes in the pharyngeal
endoderm using the Foxa2mcm cre driver (Park et al., 2008). To this
end, we have examined the thyroid gland in Fgfr1ﬂox/−;Fgfr2ﬂox/−;Fox-
a2mcm/+ E18.5 embryos. Results showed that the thyroids of these
mutants were not signiﬁcantly different from those of control
littermates (Supplementary Fig. 3). Thus, the expression of these
two receptor genes in the pharyngeal endoderm appears to be
dispensable for thyroid development. Next, we have tested the
pharyngeal endoderm expression of the other two receptors, Fgfr3
(by in situ hybridization) and Fgfr4 (by in situ hybridization and
immunohistochemistry). Results showed that at E8.5 and E9.5, Fgfr3 is
very weakly expressed (Supplementary Fig. 4) while Fgfr4 is not
Fig. 5. Fgf8 expression in the Tbx1 domain is able to rescue the Tbx1−/− thyroid phenotype. Histological analyses and corresponding 3D reconstructions of wild type (a, a'), Tbx1−/−
(b, b'), Tbx1Cre/+;Fgf8ﬂox/− (c, c') and Tbx1Fgf8/− thyroids at E18.5. The two colors in the a' panel indicate the left (white) and right (red) lobes. Note the increased size but abnormal shape
of the rescued thyroid of Tbx1 mutant embryos expressing Fgf8 from the Tbx1 domain (d'). The scale bar is 50 μm.
115G. Lania et al. / Developmental Biology 328 (2009) 109–117expressed at this stage (although it has been shown to be expressed in
the pharyngeal endoderm at earlier stages (Serls et al., 2005)) (data
not shown).
Discussion
Thyroid organogenesis is associated with the expression of a set of
transcription factor-encoding genes, Nkx2-1, Foxe1, Pax8 and Hhex1
(Parlato et al., 2004). Although these factors are also expressed in
other embryonic tissues, they are co-expressed only in the endoder-
mal cells fated to become TFC. Mouse knockout data have demon-
strated their key role in thyroid organogenesis. In Nkx2-1−/− or Pax8−/−
embryos, the thyroid primordium forms but by E11.5 it degenerates
(Mansouri et al., 1998; Minoo et al., 1999). In Hhex1−/− embryos, the
thyroid primordium forms and expresses Nkx2-1, Foxe1 and Pax8, but
at later stages their expression is downregulated and the thyroid is
small (Parlato et al., 2004). In Foxe1−/− embryos, the thyroid
primordium forms but does not migrate properly. Thus, none of
these transcription factors is individually required for thyroid
speciﬁcation or primordium formation. There are also examples of
genes that are not expressed in the thyroid but that affect its
development. For example, Hoxa3−/− and Eya1−/−mutants have thyroid
hypoplasia. In both cases, thyroid defects have been interpreted as
being secondary to failed development of the ultimobranchial bodies
(Manley and Capecchi, 1995; Xu et al., 2002).Table 3
Cell count of thyroid primordia of Fgf8-rescued embryos compared to wild type
Age Tbx1+/+ Tbx1Fgf8/− Tbx1Fgf8/Fgf8
Som. n cells Som. n cells Som. n cells
E10 34 s 395 34 s 539 34 s 434
34 s 417 34 s 331 34 s 564
34 s 303
P=0.42 P=0.17
P values indicate that the size of primordia in rescued embryos is not signiﬁcantly
different from that of wild type embryos.Congenital hypothyroidism has been reported in several cases of
22q11DS patients, although it is not a common feature of the
syndrome (Weinzimer et al., 1998). TBX1 is the major candidate
gene in this syndrome, and Tbx1mouse mutants present with a small
thyroid, suggesting that the gene contributes, directly or indirectly, to
thyroid development (Liao et al., 2004). Recently, it has been
suggested that the bilobation defect of the thyroid in Tbx1-null mice
could be due to failure of the thyroid primordium to establish a
contact with the aortic sac, which normally occurs at around E11.5–12
(Fagman et al., 2007), possibly through failed signaling between
endothelial cells and primordium. Our data presented here revealed
that Tbx1 has a much earlier role in thyroid size, as the primordium is
smaller from E9. In order to exclude a role of Tbx1 in the endothelium
adjacent to the primordium, we ablated the gene in endothelial cells
using the Tie2-Cre driver. Results showed that the thyroid of Tie2-Cre;
Tbx1ﬂox/− embryos at E18.5 was of normal size (Supplementary Fig. 5).
The role of Tbx1 in the thyroid appears to be limited to regulating
the number of cells of the primordium and does not appear to be
involved in differentiation of thyroid precursors, as the expression of
thyroid speciﬁc markers was not affected in Tbx1mutants. In addition,
the mutant thyroid primordium does not regress and is still capable of
growing, although it will never reach the normal, ﬁnal size. This
suggests that the primary defect is at or precedes primordium
formation. Conditional ablation of Tbx1 in the mesoderm is sufﬁcient
to recapitulate the null thyroid phenotype, thus indicating that the
mesoderm plays a critical role in signaling to the developing thyroid or
their progenitors. We show that loss of Tbx1 in the mesoderm is
associated with reduced cell proliferation in the pharyngeal endo-
derm of early embryos, thus providing a possible explanation as to
why the primordium is small. We have tested the hypothesis that one
of the possible Tbx1-dependent signals critical for thyroid growth is
Fgf8. Indeed, conditional ablation of Fgf8 in Tbx1-expressing cells
causes severe early and late thyroid hypoplasia, similarly to Tbx1
ablation. Conversely, forced expression of Fgf8 in the Tbx1 expression
domain, partially rescues the early and late Tbx1−/− thyroid phenotype.
Endogenous Fgf8 expression in the mesoderm near the thyroid
116 G. Lania et al. / Developmental Biology 328 (2009) 109–117primordium is only detectable in early embryogenesis (up to approx.
E9.0), consistent with the early appearance of the Tbx1 mutant
phenotype. In an attempt to determine whether the tissue targeted by
Fgf8 is the pharyngeal endoderm, we have tested the requirement of
Fgfr1 and Fgfr2 in this tissue using conditional deletion. Fgfr1 and
Fgfr2 are expressed in the pharyngeal endoderm (Moon et al., 2006;
Wright et al., 2003). Results indicated that compound deletion of these
two receptors does not cause thyroid abnormalities suggesting that
the relevant receptors may be Fgfr3, weakly expressed in the
pharyngeal endoderm, and/or Fgfr4, expressed in the pharyngeal
endoderm at the 7 somite stage (Serls et al., 2005) but not at E9.0. An
alternative possibility is that the target tissue is a non-endodermal
tissue that, in turn, signals to thyroid precursors.
The Fgf8-rescued thyroids are misshapen as they do not show
distinct bilobation. This may be due to at least four reasons. First, Tbx1
ablation affects a number of genes, including other members of the
FGF family, most notably Fgf10, which is also required for thyroid
development (Ohuchi et al., 2000) and is expressed in the mesoderm.
Because deletion of Fgf8 is sufﬁcient to cause thyroid hypoplasia, it is
possible that the two ligands have distinct roles in thyroid develop-
ment. Second, forced expression of Fgf8 from the Tbx1 locus does not
rescue any of the major Tbx1−/− phenotypic ﬁndings in Tbx1Fgf8/−
embryos (Vitelli et al., 2006), including the profound dysmorphogen-
esis of the pharyngeal apparatus as a whole. Thus, the “rescued”
thyroid grows within a highly abnormal anatomical environment,
which could explain the abnormal shape. Third, Tbx1Fgf8/− embryos,
like Tbx1−/− embryos, do not develop 4th pharyngeal pouches, thus the
rescued thyroid would not have the ultimobranchial body-derived
component. Fourth, size and bilobation of the thyroid may be
regulated by different mechanisms. For example, bilobation may be
achieved through physical interactions with arteries (which are
abnormal in Tbx1−/− embryos and not rescued by forced expression
of Fgf8), as previously suggested (Alt et al., 2006; Fagman et al., 2007;
Liao et al., 2004).
Our data demonstrate an important role for Fgf8 in mammalian
thyroid development and are consistent with recent ﬁndings in the
Zebraﬁsh model (Wendl et al., 2007). In addition, we show that Tbx1 is
a critical regulator of Fgf8 expression relevant to thyroid development.
A Tbx1-responsive enhancer has been previously demonstrated in the
Fgf8 gene (Hu et al., 2004). Thus, Tbx1 regulates, via Fgf8, the size of
the early thyroid primordium. We hypothesize that this function is
operated by regulating the proliferation of endodermal progenitors of
thyrocytes. Direct demonstration of this mechanism will require
positive identiﬁcation of these progenitors, which is not currently
possible.
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